Non-invasive cerebellar stimulation

Last updated

Non-invasive cerebellar stimulation is the application of non-invasive neurostimulation techniques on the cerebellum to modify its electrical activity. Techniques such as transcranial magnetic stimulation (TMS) or transcranial direct current stimulation (tDCS) can be used. [1] The cerebellum is a high potential target for neuromodulation of neurological and psychiatric disorders due to the high density of neurons in its superficial layer, its electrical properties, and its participation in numerous closed-loop circuits involved in motor, cognitive, and emotional functions. [2]

Contents

Cerebellar TMS is a relatively new field that is undergoing experimental research. A review of scientific literature (2024) has identified hypotheses of underlying processes of different non-invasive neurostimulation techniques. [3] Data analysis revealed that mitochondrial activity plays a central role in all of them. This insight and findings from an analysis of the mother-fetus neurocognitive model [4] constituted the hypothesis of natural brain stimulation. According to this hypothesis, the interactions within the mother-fetus bio-system of acoustic waves, electromagnetic fields, and chemical interactions synchronize their brain oscillations, affecting neuroplasticity in the fetus. [3] At the same time, ecological dynamics during the mother's intentional acts provide a clue to the fetus's nervous system, linking synaptic activity with appropriate stimuli. [3] These processes enable the child's nervous system to evolve with adequate biological sentience. During pregnancy, the mother's body produces this set of physical interactions that provide natural neurostimulation to form the balanced nervous system in the child. [3] Therefore, the balanced architecture of the child's nervous system appears with specific cognitive functions, contributing to the beginning of cognition. [3] It is thought that existing neurostimulation techniques are just exceptional cases of this universal natural sequence of actions, a part of a natural flow of physical interactions in nervous system development during pregnancy. However, there is not yet sufficient evidence of the therapeutic effects of cerebellar TMS, [5] although some successful results have been reported in other clinical studies of TMS used to treat the frontal lobe. [6] Probably because they do not yet consider natural neurostimulation properties.

NICS is a neural modulation technique, showing capability to rehabilitate the brain functions of patients undergoing a plethora of neurological or psychiatric diseases. [7] There are 3 forms of NICS which are primarily used; transcranial magnetic stimulation (TMS), transcranial direct current stimulation (tDCS) and transcranial alternating current stimulation (tACS). [1] NICS targets the cerebellum, due to the high density of neurons at its superficial layer (the cerebellar cortex), the electrical properties, and network to neural circuits (involved in motor, cognitive, and emotional functions). [2] Due to the success of clinical trials in response to rehabilitating sensorimotor functions and cognition, more NICS research is being invested into. [8] NICS has the potential to attack multiple neurological and psychiatric disorders, although NICS are still not included and heavily advocated in clinical treatment. This is due to contingent conclusions regarding NICS effects. [9] Further research is still required to confirm and identify the optimal parameters to target these regions.

Existing NICS methods

The three most distinguished NICS methods include transcranial magnetic stimulation (TMS), transcranial direct-current stimulation (tDCS) and transcranial alternating current stimulation (tACS). All methods involve the targeting to the cerebellar region of interest. However collectively the effects of these treatments are not fully disclosed. [10] Multiple theories have been suggested; 1) NICS influences the excitability of cerebellar neurons and in the connectivity between cerebellar and other brain regions, which henceforth alters the cerebellums motor and cognitive functions. [11] 2) NICS can induce variations in plasticity (ability of nervous system to adapt its activity in response to stimuli), which create long-lasting effects behaviour and cognition. [12] 3) NICS induces selectivity of the activation and/or inhibition of specific neural circuits within the cerebellum. [1]

Transcranial magnetic stimulation (TMS)

Figure 1: Image derived from psych scene hub displaying the general mechanism of TMS. A small coil is placed near the scalp, whereby a magnetic field is applied to induce an electrical field within the brains outer cortex. The coil is generally directed above the motor cortex (region which primarily generates neural impulses). Transcranial magnetic stimulation (TMS).png
Figure 1: Image derived from psych scene hub displaying the general mechanism of TMS. A small coil is placed near the scalp, whereby a magnetic field is applied to induce an electrical field within the brains outer cortex. The coil is generally directed above the motor cortex (region which primarily generates neural impulses).
Figure 2: Image of Dr. Oscar Morales (medical director of TMS service at McLean Hospital) displaying how the TMS coil is positioned. This equipment was directed for the treatment of OCD. Transcranial Magnetic Stimulation TMS for OCD.jpg
Figure 2: Image of Dr. Oscar Morales (medical director of TMS service at McLean Hospital) displaying how the TMS coil is positioned. This equipment was directed for the treatment of OCD.

TMS utilises a magnetic field to induce a brief electrical impulse which stimulates neurons within the cerebral cortex. [15] This targets the cerebral cortex through electromagnetic induction. Its general mechanism is applying a magnetic field in the form of coil to the scalp which then influences your motor cortex. [16] TMS itself has variations in terms of magnet strength, pulse frequency, pulse patterns (rTMS), magnetic coil type and stimulation target. [17] Depending on its target use, these factors can be manipulated specific to the target disease. [18] [ citation needed ] This is a method which is FDA approved and primarily utilized for mental illnesses such as depression. [18] [ citation needed ]

Transcranial direct current stimulation (tDCS)

tDCS involves the application of a weak direct electrical current to the scalp which flows through underlying brain tissue and modulates the activity of the neurons within the targeted region. [19] When directed on the cerebellum, tDCs can increase or suppress the excitability of neurons. [20] This is the dependent on the current; an anode is placed on the target region and a cathode on the reference region, I.e. excitability of neurons is enhanced in the target region and alternatively suppressed in the reference region. [21]

Transcranial alternating current stimulation (tACS)

tACS involves the utilisation of an alternating current on the target region which is stated to modulate activity of brain regions through entraining neuronal oscillations and hence enhance cerebellar function. [22]

History

The first reports of NICS date back to the early 1960s, when German neurologist Oskar Vogt first used electrical stimulation to stimulate the cerebellum. [23] Results of this study indicated the ability of electrical stimulation in the cerebellum to induce chances in muscle tone and movement. [23] However, the use of an invasive procedure limited the clinical application and relevance of the study. The development of transcranial magnetic stimulation (TMS) in the 1980s opened new possibilities for the application NICS, and brain imaging techniques developed in the latter half of the 20th century later revealed the effects of cerebellum stimulation on higher cognitive functions such as language, emotion and attention. [24] In the 1990s, researchers began to study the effects of TMS in humans. Since then, extensive studies have been conducted exploring the impact of NICS on cerebellar function and its possibilities in clinical contexts. [25]

Medical Use

Currently NICS treatments are not being heavily advocated by medical practitioners due to the insufficient research surrounding their mechanisms. [9] However, there are multiple clinical trials which have deduced that using such techniques have in fact benefited patients with neurological and psychiatric disorders. [9]

TMS has been approved by the US Food and Drug Administration (FDA) for the treatment of major depressive disorders who do not respond to the oral medications (antidepressants). [26] [ citation needed ] Clinical trials additionally concluded positive results in relation to improving Obsessive–compulsive disorder (OCD), post-traumatic stress disorder (PTSD), and schizophrenia. [27] TMS has also been investigated for its potential use in the treatment of chronic pain and stroke rehabilitation. [28]

tDCS likewise have produced positive results in the treatment of disorders such as depression, anxiety, chronic pain and stroke rehabilitation. [29] However, such evidence is still insufficient to be fully implemented in clinical practice and hence does not have FDA approval. Such research is to be further explored. [30]

tACS are similar to this; having promising results in clinical trials but have insufficient research and understanding of mechanisms to further implement this in clinical practice. [31]

Neurological disorders

Cerebellar ataxia

Cerebellar Ataxia are a complex group of degenerative disorders which impair voluntary movements and are associated with the cerebellum. [9] The cerebellum plays a significant role in motor coordination, balance and posture, and its dysfunction is what results in Cerebellar Ataxia. [9] Currently, there are no effective disease-modifying therapies for this condition. [9] However, NICS has demonstrated potential as a therapeutic approach to address the clinical symptoms of patients with these debilitating disorders. [9] The application of NICS techniques such as TMS and tDCS enable the alleviation of symptoms through improved motor function, although further research is needed before it can be broadly utilised within clinical context. [9]

Dystonia

Dystonia is a multifaceted disorder that stems from cerebellar dysfunction, and it is marked by the development of uncontrollable muscle contractions. [32] The capacity to restore functional cerebellar processing after impairments suggests NICS as a potential treatment to aid in the control of these symptoms within certain patients. [32] The approach of TMS and tDCS provides a novel treatment target, however, the efficacy of using NICS within these parameters are undetermined. [32]

Psychiatric disorders

Schizophrenia

Schizophrenia is a psychotic disorder resulting from the impairment of the cerebellum, and it is characterised by hallucinations, distorted thinking and delusions. [33] The NICS technique of tDCS is commonly applied to Schizophrenia to alleviate symptoms and enhance cognitive, social, behavioural and emotional functions. [33] However, clinical trials are needed in order to examine the possible therapeutic potential of tDCS in Schizophrenia. [33]

Benefits

NICS are a safer treatment option unlike invasive procedures and treatment options which require incisions and anaesthesia. [9] These characteristics make it relatively safe and uncomplicated to administer. NICS enables patients to be treated without the hassle of being hospitalised or sedated as the procedure is often done in an outpatient setting. [9] This is in particularly useful for patients who opt for untraditional treatments (avoiding surgery or use of drugs).

NICS are considered to be a cost-effective option for patients. The cost of these treatments may vary in the parameters for an individual patient, although cumulatively this is still a cost-effective option if the alternative is continuous drugs or referring to surgery. [30]

Despite the limited information and research available for this topic, NICS withhold potential in the medical field to improve a variety of neuronal and psychiatric disorders.

Limitations and adverse effects

Despite being reported as mostly safe, adverse effects still exist; which influence the patients’ decision to pursue this form of treatment. The most common side effect reported are mild and transient which include headaches, scalp discomfort and tingling sensations. However, there are more severe side-effects reported including induced seizures, pain, syncope, transient induction of hypomania, hearing loss, transient impairment of working memory etc. [34] [ citation needed ]

Such implications are due to the lack of research, particularly information regarding the effectiveness and the most optimal method of treatment. Techniques in inducing optimal parameters such as the intensity, target region of the magnetic field and current, duration of pulses, and type of treatment are still unspecified. Such methods (particularly RMS and tDCS) lack specific targeting to certain regions, which thus affects other regions of the brain which otherwise do not require intervention. [35] Additionally, the methods included are not generalisable to all patients. There is more inter-individual variability in the response to cerebellar stimulation, thereafter it requires the calculation and determination of the specific target region for a patient. [9] This information is still inconclusive and requires further research on how to optimally determine this.

The noted above issue of an undefined dose (time and field technical parameters) for appropriate and healthy stimulation can destroy healthy cells during the treatment procedure. In many current noninvasive electrical and magnetic therapies, stimulation involves excessive exposure of the patient to an intense field that exceeds natural currents and electromagnetic fields in the brain by times and even orders of magnitude. [3]

Due to the lack of standardisation in the protocol of administering these interventions, NICS's are not currently suitable/advocated for application in clinical practice. [11] In order for effective treatment to occur, specified protocols must be administered for each patient, which is impractical in a wide scale population. Due to the limited and mixed conclusions of studies, patients and medical practitioners alike may be hesitant to use and invest in these non-invasive methods. Instead more traditional, invasive methods are preferred; including oral medications or practical therapies. [9]

See also

Related Research Articles

<span class="mw-page-title-main">Transcranial magnetic stimulation</span> Brain stimulation using magnetic fields

Transcranial magnetic stimulation (TMS) is a noninvasive neurotherapy, a form of brain stimulation in which a changing magnetic field is used to induce an electric current at a specific area of the brain through electromagnetic induction. An electric pulse generator, or stimulator, is connected to a magnetic coil connected to the scalp. The stimulator generates a changing electric current within the coil which creates a varying magnetic field, inducing a current within a region in the brain itself.

<span class="mw-page-title-main">Brodmann area 46</span> Brain area

Brodmann area 46, or BA46, is part of the frontal cortex in the human brain. It is between BA10 and BA45.

Neurotechnology encompasses any method or electronic device which interfaces with the nervous system to monitor or modulate neural activity.

Neurohacking is a subclass of biohacking, focused specifically on the brain. Neurohackers seek to better themselves or others by “hacking the brain” to improve reflexes, learn faster, or treat psychological disorders. The modern neurohacking movement has been around since the 1980s. However, herbal supplements have been used to increase brain function for hundreds of years. After a brief period marked by a lack of research in the area, neurohacking started regaining interest in the early 2000s. Currently, most neurohacking is performed via do-it-yourself (DIY) methods by in-home users.

Cerebellar ataxia is a form of ataxia originating in the cerebellum. Non-progressive congenital ataxia (NPCA) is a classical presentation of cerebral ataxias.

Intention tremor is a dyskinetic disorder characterized by a broad, coarse, and low-frequency tremor evident during deliberate and visually-guided movement. An intention tremor is usually perpendicular to the direction of movement. When experiencing an intention tremor, one often overshoots or undershoots one's target, a condition known as dysmetria. Intention tremor is the result of dysfunction of the cerebellum, particularly on the same side as the tremor in the lateral zone, which controls visually guided movements. Depending on the location of cerebellar damage, these tremors can be either unilateral or bilateral.

<span class="mw-page-title-main">Transcranial direct-current stimulation</span> Technique of brain electric stimulation therapy

Transcranial direct current stimulation (tDCS) is a form of neuromodulation that uses constant, low direct current delivered via electrodes on the head. This type of neurotherapy was originally developed to help patients with brain injuries or neuropsychiatric conditions such as major depressive disorder. It can be contrasted with cranial electrotherapy stimulation, which generally uses alternating current the same way, as well as transcranial magnetic stimulation.

Integrative neuroscience is the study of neuroscience that works to unify functional organization data to better understand complex structures and behaviors. The relationship between structure and function, and how the regions and functions connect to each other. Different parts of the brain carrying out different tasks, interconnecting to come together allowing complex behavior. Integrative neuroscience works to fill gaps in knowledge that can largely be accomplished with data sharing, to create understanding of systems, currently being applied to simulation neuroscience: Computer Modeling of the brain that integrates functional groups together.

Neurostimulation is the purposeful modulation of the nervous system's activity using invasive or non-invasive means. Neurostimulation usually refers to the electromagnetic approaches to neuromodulation.

Cortical stimulation mapping (CSM) is a type of electrocorticography that involves a physically invasive procedure and aims to localize the function of specific brain regions through direct electrical stimulation of the cerebral cortex. It remains one of the earliest methods of analyzing the brain and has allowed researchers to study the relationship between cortical structure and systemic function. Cortical stimulation mapping is used for a number of clinical and therapeutic applications, and remains the preferred method for the pre-surgical mapping of the motor cortex and language areas to prevent unnecessary functional damage. There are also some clinical applications for cortical stimulation mapping, such as the treatment of epilepsy.

Cerebellar cognitive affective syndrome (CCAS), also called Schmahmann's syndrome is a condition that follows from lesions (damage) to the cerebellum of the brain. It refers to a constellation of deficits in the cognitive domains of executive function, spatial cognition, language, and affect resulting from damage to the cerebellum. Impairments of executive function include problems with planning, set-shifting, abstract reasoning, verbal fluency, and working memory, and there is often perseveration, distractibility and inattention. Language problems include dysprosodia, agrammatism and mild anomia. Deficits in spatial cognition produce visual–spatial disorganization and impaired visual–spatial memory. Personality changes manifest as blunting of affect or disinhibited and inappropriate behavior. These cognitive impairments result in an overall lowering of intellectual function. CCAS challenges the traditional view of the cerebellum being responsible solely for regulation of motor functions. It is now thought that the cerebellum is responsible for monitoring both motor and nonmotor functions. The nonmotor deficits described in CCAS are believed to be caused by dysfunction in cerebellar connections to the cerebral cortex and limbic system.

The temporal dynamics of music and language describes how the brain coordinates its different regions to process musical and vocal sounds. Both music and language feature rhythmic and melodic structure. Both employ a finite set of basic elements that are combined in ordered ways to create complete musical or lingual ideas.

Neuromodulation is "the alteration of nerve activity through targeted delivery of a stimulus, such as electrical stimulation or chemical agents, to specific neurological sites in the body". It is carried out to normalize – or modulate – nervous tissue function. Neuromodulation is an evolving therapy that can involve a range of electromagnetic stimuli such as a magnetic field (rTMS), an electric current, or a drug instilled directly in the subdural space. Emerging applications involve targeted introduction of genes or gene regulators and light (optogenetics), and by 2014, these had been at minimum demonstrated in mammalian models, or first-in-human data had been acquired. The most clinical experience has been with electrical stimulation.

Transcranial random noise stimulation (tRNS) is a non-invasive brain stimulation technique and a form of transcranial electrical stimulation (tES). Terney et al from Göttingen University was the first group to apply tRNS in humans in 2008. They showed that by using an alternate current along with random amplitude and frequency in healthy subjects, the motor cortex excitability increased for up to 60 minutes after 10 minutes of stimulation. The study included all the frequencies up to half of the sampling rate i.e. 640 Hz, however the positive effect was limited only to higher frequencies. Although tRNS has shown positive effects in various studies the optimal parameters, as well as the potential clinical effects of this technique, remain unclear.

Gait variability seen in Parkinson's Disorders arise due to cortical changes induced by pathophysiology of the disease process. Gait rehabilitation is focused to harness the adapted connections involved actively to control these variations during the disease progression. Gait variabilities seen are attributed to the defective inputs from the Basal Ganglia. However, there is altered activation of other cortical areas that support the deficient control to bring about a movement and maintain some functional mobility.

<span class="mw-page-title-main">Abraham Zangen</span> Israeli researcher

Abraham Zangen is an Israeli professor of neuroscience, head of the brain stimulation and behavior lab and chair of the psychobiology brain program at Ben-Gurion University of the Negev (BGU).

<span class="mw-page-title-main">Roy Hamilton (physician)</span> American neurologist and academic

Roy Hamilton is professor in the departments of Neurology, Psychiatry, and Physical Medicine and Rehabilitation at University of Pennsylvania (Penn). He is the Director of Penn's Laboratory for Cognition and Neural Stimulation (LCNS), and launched the Brain Stimulation, Translation, Innovation, and Modulation Center (brainSTIM) at the University of Pennsylvania in 2020.

<span class="mw-page-title-main">Friedhelm Hummel</span> German neuroscientist and neurologist

Friedhelm Christoph Hummel is a German neuroscientist and neurologist. A full professor at École Polytechnique Fédérale de Lausanne, he is the Defitech Chair of Clinical Neuroengineering, and the head of the Hummel Laboratory at EPFL's School of Life Sciences. He also is an associate professor of clinical neuroscience at the University of Geneva.

<span class="mw-page-title-main">Alberto Priori</span> Italian neurologist

Alberto Priori is an Italian neurologist, academic, and author. He is a Professor of Neurology at the University of Milan, Director of Neurology 1 Unit at San Paolo Hospital, and the Founder and Coordinator of Aldo Ravelli Center of the University of Milan. He also serves as President of the Neurophysiopatology Techniques Course, and Professor of Postgraduate Schools - Medicine, Healthcare, Dental Medicine at the same University.

Interventional Psychiatry is a subspecialty within the field of psychiatry, focusing on the use of procedural and device-based treatments to manage mental health disorders, particularly those resistant to conventional therapies such as pharmacotherapy and psychotherapy. This field integrates neuromodulation methods with targeted pharmacological interventions, providing options for patients who have not responded to traditional treatments.

References

  1. 1 2 3 Grimaldi G, Argyropoulos GP, Boehringer A, Celnik P, Edwards MJ, Ferrucci R, et al. (February 2014). "Non-invasive cerebellar stimulation--a consensus paper" (PDF). Cerebellum. 13 (1): 121–138. doi:10.1007/s12311-013-0514-7. PMID   23943521. S2CID   8500033.
  2. 1 2 van Dun K, Manto M (June 2018). "Non-invasive Cerebellar Stimulation: Moving Towards Clinical Applications for Cerebellar and Extra-Cerebellar Disorders". Cerebellum. 17 (3): 259–263. doi: 10.1007/s12311-017-0908-z . PMID   29282616.
  3. 1 2 3 4 5 6 Val Danilov I (2024). "The Origin of Natural Neurostimulation: A Narrative Review of Noninvasive Brain Stimulation Techniques." OBM Neurobiology 2024; 8(4): 260; https://doi:10.21926/obm.neurobiol.2404260.
  4. ↑ Val Danilov I (2024). "Child Cognitive Development with the Maternal Heartbeat: A Mother-Fetus Neurocognitive Model and Architecture for Bioengineering Systems." In International Conference on Digital Age & Technological Advances for Sustainable Development (pp. 216-223). Springer, Cham. https://doi.org/10.1007/978-3-031-75329-9_24
  5. ↑ Minks E, Kopickova M, Marecek R, Streitova H, Bares M (June 2010). "Transcranial magnetic stimulation of the cerebellum". Biomedical Papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia. 154 (2): 133–139. doi: 10.5507/bp.2010.020 . PMID   20668494.
  6. ↑ Derstine T, Lanocha K, Wahlstrom C, Hutton TM (November 2010). "Transcranial magnetic stimulation for major depressive disorder: a pragmatic approach to implementing TMS in a clinical practice". Annals of Clinical Psychiatry. 22 (4 Suppl): S4-11. PMID   21180663.
  7. ↑ He L, Guo QF, Hu Y, Tan HX, Chen Y, Wang CH, et al. (2023). "Bibliometric and visualised analysis on non-invasive cerebellar stimulation from 1995 to 2021". Frontiers in Neuroscience. 17: 1047238. doi: 10.3389/fnins.2023.1047238 . PMC   10102618 . PMID   37065918.
  8. ↑ Finisguerra A, Borgatti R, Urgesi C (2019). "Non-invasive Brain Stimulation for the Rehabilitation of Children and Adolescents With Neurodevelopmental Disorders: A Systematic Review". Frontiers in Psychology. 10: 135. doi: 10.3389/fpsyg.2019.00135 . PMC   6373438 . PMID   30787895.
  9. 1 2 3 4 5 6 7 8 9 10 11 12 Benussi A, Pascual-Leone A, Borroni B (March 2020). "Non-Invasive Cerebellar Stimulation in Neurodegenerative Ataxia: A Literature Review". International Journal of Molecular Sciences. 21 (6): 1948. doi: 10.3390/ijms21061948 . PMC   7139863 . PMID   32178459.
  10. ↑ Wu ZY, Wang YQ, Wen XP, Wang MY, Wang LN, Lu LM, Li KB (September 2022). "Does noninvasive cerebellar stimulation improve the balance and walking function of patients with stroke: A meta-analysis of randomized controlled trials". Medicine. 101 (36): e30302. doi: 10.1097/MD.0000000000030302 . PMC   10980459 . PMID   36086722. S2CID   252167479.
  11. 1 2 Ferrucci R, Mameli F, Guidi I, Mrakic-Sposta S, Vergari M, Marceglia S, et al. (August 2008). "Transcranial direct current stimulation improves recognition memory in Alzheimer disease". Neurology. 71 (7): 493–498. doi:10.1212/01.wnl.0000317060.43722.a3. PMID   18525028. S2CID   8276957.
  12. ↑ Di Nuzzo C, Ruggiero F, Cortese F, Cova I, Priori A, Ferrucci R (2018). "Non-invasive Cerebellar Stimulation in Cerebellar Disorders". CNS & Neurological Disorders Drug Targets. 17 (3): 193–198. doi:10.2174/1871527317666180404113444. PMID   29623859. S2CID   4775439.
  13. ↑ "Transcranial Magnetic Stimulation for Depression - Review of the Evidence". Psych Scene Hub. 21 March 2023. Retrieved 2023-04-13.
  14. ↑ "International OCD Foundation | Transcranial Magnetic Stimulation (TMS) for OCD". International OCD Foundation. Retrieved 2023-03-28.
  15. ↑ Siebner HR, Hartwigsen G, Kassuba T, Rothwell JC (October 2009). "How does transcranial magnetic stimulation modify neuronal activity in the brain? Implications for studies of cognition". Cortex; A Journal Devoted to the Study of the Nervous System and Behavior. 45 (9): 1035–1042. doi:10.1016/j.cortex.2009.02.007. PMC   2997692 . PMID   19371866.
  16. ↑ "How Does TMS Work?". Department of Psychiatry. Retrieved 2023-04-13.
  17. ↑ "TMS (Transcranial Magnetic Stimulation): What It Is". Cleveland Clinic. Retrieved 2023-03-28.
  18. 1 2 "Transcranial Magnetic Stimulation (TMS) to Treat Symptoms of Depression: Americas TMS Center: TMS Specialists". www.americastms.com. Retrieved 2023-04-13.
  19. ↑ Thair H, Holloway AL, Newport R, Smith AD (2017). "Transcranial Direct Current Stimulation (tDCS): A Beginner's Guide for Design and Implementation". Frontiers in Neuroscience. 11: 641. doi: 10.3389/fnins.2017.00641 . PMC   5702643 . PMID   29213226.
  20. ↑ D'Urso G, Bruzzese D, Ferrucci R, Priori A, Pascotto A, Galderisi S, et al. (2015). "Transcranial direct current stimulation for hyperactivity and noncompliance in autistic disorder". The World Journal of Biological Psychiatry. 16 (5): 361–366. doi:10.3109/15622975.2015.1014411. PMID   25800799. S2CID   39786973.
  21. ↑ Nitsche MA, Paulus W (2011). "Transcranial direct current stimulation--update 2011". Restorative Neurology and Neuroscience. 29 (6): 463–492. doi:10.3233/RNN-2011-0618. PMID   22085959.
  22. ↑ Grimaldi G, Manto M (June 2012). "Topography of cerebellar deficits in humans". Cerebellum. 11 (2): 336–351. doi:10.1007/s12311-011-0247-4. PMID   21240580. S2CID   17468515.
  23. 1 2 Klatzo I (2003). "Cécile & Oskar Vogt: The significance of their contributions in modern neuroscience". In Kuroiwa T, Baethmann A, Czernicki Z, Hoff JT (eds.). Brain Edema XII. Vol. 86. Vienna: Springer Vienna. pp. 29–32. doi:10.1007/978-3-7091-0651-8_6. ISBN   978-3-7091-7220-9. PMID   14753398 . Retrieved 2023-03-28.
  24. ↑ Luber B, McClintock SM, Lisanby SH (March 2013). "Applications of transcranial magnetic stimulation and magnetic seizure therapy in the study and treatment of disorders related to cerebral aging". Dialogues in Clinical Neuroscience. 15 (1): 87–98. doi:10.31887/DCNS.2013.15.1/bluber. PMC   3622472 . PMID   23576892.
  25. ↑ Dong L, Ma W, Wang Q, Pan X, Wang Y, Han C, Meng P (2022-04-27). "The Effect of Repetitive Transcranial Magnetic Stimulation of Cerebellar Swallowing Cortex on Brain Neural Activities: A Resting-State fMRI Study". Frontiers in Human Neuroscience. 16: 802996. doi: 10.3389/fnhum.2022.802996 . PMC   9094708 . PMID   35572005.
  26. ↑ Center for Devices and Radiological Health (2021-03-25). "Repetitive Transcranial Magnetic Stimulation (rTMS) Systems - Class II Special Controls Guidance for Industry and FDA Staff". FDA.
  27. ↑ Aleman A (August 2013). "Use of repetitive transcranial magnetic stimulation for treatment in psychiatry". Clinical Psychopharmacology and Neuroscience. 11 (2): 53–59. doi:10.9758/cpn.2013.11.2.53. PMC   3766755 . PMID   24023548.
  28. ↑ George MS, Lisanby SH, Sackeim HA (April 1999). "Transcranial magnetic stimulation: applications in neuropsychiatry". Archives of General Psychiatry. 56 (4): 300–311. doi:10.1001/archpsyc.56.4.300. PMID   10197824.
  29. ↑ Hao W, Liu Y, Gao Y, Gong X, Ning Y (2023-01-18). "Transcranial direct current stimulation for the treatment of post-stroke depression: A systematic review". Frontiers in Neurology. 13: 955209. doi: 10.3389/fneur.2022.955209 . PMC   9893893 . PMID   36742053.
  30. 1 2 Bikson M, Grossman P, Thomas C, Zannou AL, Jiang J, Adnan T, et al. (2016-06-14). "Safety of Transcranial Direct Current Stimulation: Evidence Based Update 2016". Brain Stimulation. 9 (5): 641–661. doi:10.1016/j.brs.2016.06.004. PMC   5007190 . PMID   27372845.
  31. ↑ Herrmann CS, Rach S, Neuling T, Strüber D (2013). "Transcranial alternating current stimulation: a review of the underlying mechanisms and modulation of cognitive processes". Frontiers in Human Neuroscience. 7: 279. doi: 10.3389/fnhum.2013.00279 . PMC   3682121 . PMID   23785325.
  32. 1 2 3 Graetz L, Bradnam L (2013-12-01). "Non-invasive cerebellar stimulation in dystonia". Translational Neuroscience. 4 (4): 458–465. doi:10.2478/s13380-013-0143-0. hdl: 10453/116296 . ISSN   2081-6936. S2CID   55216707.
  33. 1 2 3 Laidi C, Levenes C, Suarez-Perez A, Février C, Durand F, Bouaziz N, Januel D (2020-03-17). "Cognitive Impact of Cerebellar Non-invasive Stimulation in a Patient With Schizophrenia". Frontiers in Psychiatry. 11: 174. doi: 10.3389/fpsyt.2020.00174 . PMC   7090138 . PMID   32256404.
  34. ↑ "Veljko Dubljevic". College of Humanities and Social Sciences. Retrieved 2023-03-28.
  35. ↑ Sparing R, Mottaghy FM (April 2008). "Noninvasive brain stimulation with transcranial magnetic or direct current stimulation (TMS/tDCS)-From insights into human memory to therapy of its dysfunction". Methods. 44 (4): 329–337. doi:10.1016/j.ymeth.2007.02.001. PMID   18374276.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.